University Medical Center Groningen
835
153
189
384
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.2%
52 terminated/withdrawn out of 835 trials
88.1%
+1.6% vs industry average
11%
94 trials in Phase 3/4
5%
19 of 384 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (835)
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Role: lead
Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients
Role: lead
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Role: lead
Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer
Role: collaborator
Immediate Loading of Implants in the Aesthetic Zone Using Three-dimensionally Printed Provisional Crowns: a 1-year Prospective Case Series Study
Role: lead
Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.
Role: lead
Glioblastoma Targeted Treatment Option Maximization by WGS
Role: collaborator
Hybrid Atrial Fibrillation Ablation Registry
Role: lead
Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline
Role: collaborator
Improving Personal Recovery After Depression With a Blended Module (STAIRS)
Role: lead
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Role: lead
Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)
Role: collaborator
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma
Role: collaborator
Heterogeneity of Critical Illness: a Cohort Study
Role: lead
Simple Observational Critical Care Studies
Role: lead
COVID-19 Follow up Intensive Care Studies
Role: lead
No Guts No Glory Probiotics
Role: lead
AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
Role: lead
The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study
Role: lead
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
Role: lead